Revanesse Ultra with Lido (2x1,2 ml)

Avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator that can increase post-filler swelling and worsen bruising at the injection site.

This treatment is strictly contraindicated. There is no clinical safety data regarding the use of cross-linked HA and lidocaine during fetal development. We recommend postponing elective fillers until after childbirth.

The formulation contains 25 mg/ml of cross-linked Hyaluronic Acid of non-animal origin and 0.3% Lidocaine hydrochloride for a comfortable procedural experience.

Dosage is individualized based on the depth of the wrinkles or the level of volume restoration required. The 1.2 ml syringe volume allows for a more extensive correction of the mid-face or lips compared to standard 1 ml syringes. Practitioners should evaluate if 0.5 ml of lip filler is enough for initial hydration before utilizing the full density of Revanesse Ultra for structural augmentation.

Expect transient side effects such as localized swelling, redness, and potential purple bruising at the injection site. These are standard and usually resolve within 7 days. To ensure a quick recovery, patients must follow our expert aftercare guide. Any persistent blanching requires immediate evaluation for vascular occlusion.

The spherical particle technology of Revanesse allows the gel to move naturally with the face while maintaining high G-prime support. Unlike superficial skin boosters, Revanesse Ultra provides the structural integrity needed for mid-to-deep dermal support and volume retention.

Injection is not recommended for nursing mothers. It is advised to wait until the breastfeeding period has concluded to ensure the highest safety for both mother and infant.